Children with atopic eczema experiencing increased disease severity in the pollen season more often have hay fever at a young age and a dark skin type.
atopic eczema/dermatitis
hay fever
phenotype
pollen season
skin type
Journal
The Journal of dermatology
ISSN: 1346-8138
Titre abrégé: J Dermatol
Pays: England
ID NLM: 7600545
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
revised:
10
12
2020
received:
09
11
2020
accepted:
11
12
2020
pubmed:
7
1
2021
medline:
15
5
2021
entrez:
6
1
2021
Statut:
ppublish
Résumé
Children with atopic eczema are known to experience seasonal variations in disease severity, with winter being the season in which severity generally increases. There is a lack of knowledge about the subgroup of children that experiences increased severity in spring and summer months. We aimed to investigate which phenotype characteristics best describe children flaring in the pollen season. A retrospective database analysis was conducted, including 110 children with difficult-to-treat atopic eczema aged 0-17 years. Relevant outcome parameters were extracted from medical records. In our population, 36% (n = 40/110) of children reported flares of atopic eczema in the pollen season. These children were more often sensitized to one or more types of pollen (73% [n = 29/40] vs. 28% [n = 10/36], p < 0.0001) and had more patient-reported hay fever (70% [n = 28/40] vs. 19% [n = 7/36], p < 0.0001), compared with children who do not flare in the pollen season. Moreover, children flaring in the pollen season more often had a dark skin type (78% [n = 31/40] vs. 44% [n = 16/36], p = 0.003). Based on stepwise multivariable analyses, children flaring in the pollen season were characterized by the combination of younger age, hay fever, and dark skin type (C-statistic: 0.86). In conclusion, patient-reported flares in spring and summer are experienced by one-third of children with difficult-to-treat atopic eczema. This phenotype can be characterized as young children having hay fever and a dark skin type and can be identified based on clinical parameters alone without the need to perform immunoglobulin E blood testing or skin prick tests.
Identifiants
pubmed: 33404119
doi: 10.1111/1346-8138.15750
pmc: PMC8048828
doi:
Substances chimiques
Allergens
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
470-475Informations de copyright
© 2021 The Authors. The Journal of Dermatology published by John Wiley & Sons Australia, Ltd on behalf of Japanese Dermatological Association.
Références
J Eur Acad Dermatol Venereol. 2016 Feb;30(2):223-49
pubmed: 26449379
Allergy Asthma Proc. 2017 Jul 1;38(4):294-299
pubmed: 28668109
Contact Dermatitis. 2016 Jan;74(1):56-8
pubmed: 26690280
Exp Dermatol. 2019 Dec;28(12):1416-1421
pubmed: 31152459
Yonsei Med J. 2019 Jun;60(6):570-577
pubmed: 31124341
Br J Dermatol. 2008 Mar;158(3):539-43
pubmed: 18067476
Allergy. 2009 Oct;64(10):1507-15
pubmed: 19772516
Nat Genet. 2006 Apr;38(4):441-6
pubmed: 16550169
J Invest Dermatol. 2009 Aug;129(8):1878-91
pubmed: 19357709
Allergy Asthma Proc. 2015 Sep-Oct;36(5):e81-5
pubmed: 26314808
Scand J Public Health. 2014 Mar;42(2):120-7
pubmed: 24089102
J Dermatol Sci. 2018 Feb;89(2):105-111
pubmed: 29169766
Lancet. 2020 Aug 1;396(10247):345-360
pubmed: 32738956
Eur J Pain. 2016 Jan;20(1):47-50
pubmed: 26415614
J Invest Dermatol. 2005 Mar;124(3):514-23
pubmed: 15737191
J Pediatr. 2007 Aug;151(2):187-91
pubmed: 17643776
J Invest Dermatol. 2011 Jan;131(1):67-73
pubmed: 20739951
J Am Acad Dermatol. 1995 Feb;32(2 Pt 1):212-7
pubmed: 7829705
Cochrane Database Syst Rev. 2016 Feb 12;2:CD008774
pubmed: 26871981
J Dermatol. 2001 May;28(5):244-7
pubmed: 11436360
J Allergy Clin Immunol. 2008 Oct;122(4):820-827.e9
pubmed: 19014772
J Paediatr Child Health. 2013 Apr;49(4):272-7
pubmed: 23510211
J Dtsch Dermatol Ges. 2009 Oct;7(10):899-910
pubmed: 19682176